产品详情
靶点信息
JAK2 | SET-2 | TYK2 | JAK3 | JAK1 |
1.1 nM | 60 nM | 66 nM | 75 nM | 360 nM |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.12 mL | 115.6 mL | 231.2 mL |
0.5 mM | 4.62 mL | 23.12 mL | 46.24 mL |
1 mM | 2.31 mL | 11.56 mL | 23.12 mL |
5 mM | 0.46 mL | 2.31 mL | 4.62 mL |
*The above data is based on the productmolecular weight 432.52. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11241 |
---|---|
MECHANISM OF ACTION | Inhibitor |
M. Wt | 432.52 |
Formula | C23H28N8O |
Solubility | DMSO |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1271022-90-2 |
Synonyms | BMS911543, BMS 911543 |
SMILES | CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6 |
产品标签
Product Questions
Product Questions
AC220 (Quizartinib)
AC220 (Quizartinib)是一种有效的选择性FLT3抑制剂,对于MC4-11和A375,IC50分别为0.56±0.3 nM和> 10 mM。
AZD 2932
AZD2932 is a potent and mutil-targeted protein tyrosine kinase inhibitor with IC50 of 8 nM, 4 nM, 7 nM, and 9 nM for VEGFR-2, PDGFRβ, Flt-3…
TG-101348 (Fedratinib, SAR302503)
TG-101348是Janus相关激酶2的口服生物利用型,ATP竞争性和选择性抑制剂,在无细胞试验中IC50为3 nM,作用于JAK…
SGI-1776 (free base)
SGI-1776 (free base)是Pim1的一种新型ATP竞争性抑制剂,在无细胞试验中的IC50为7 nM,选择性是Pim2和Pim3的50倍和10…
Pexidartinib (PLX3397)
Pexidartinib is a small-molecule receptor tyrosine kinase (RTK) inhibitor of KIT, CSF1R and FLT3 with potential antineoplastic activity.
TCS 359
TCS 359 is a potent inhibitor of FLT3 receptor tyrosine kinase (IC50 = 42 nM) that displays selectivity over a range of other kinases.